EC Number |
Inhibitors |
Structure |
---|
3.1.4.54 | 1,2-dihexanoyl-glycero-N-(3-(tetradecanoylamino)propyl)phosphoramidate |
i.e. AHP-71B, 96.6% inhibition at 1 mM |
|
3.1.4.54 | 2,4-dioxo-N-[4-(4-pyridyl)phenyl]-1H-quinazoline-6-sulfonamide |
reversible uncompetitive inhibitor, compound binds via a reversible mechanism to the enzyme's zinc center. Compound is not inhibitory to carbonic anhydrase II, neutral endopeptidase and angiotensin-converting enzyme |
|
3.1.4.54 | 2-arachidonoylglycerol |
0.05 mM, 67% loss of activity |
|
3.1.4.54 | 4-(4-(2-(3-methoxyphenyl)benzo[b]thiophen-3-yl)phenoxy)-N,N-dimethylethan-1-amine |
compound additionally inhibits human phospholipases Pld1 and Pld2 and Pseudomonas aeruginosa PldA |
|
3.1.4.54 | 4-chloromercuribenzoic acid |
- |
|
3.1.4.54 | Ca2+ |
- |
|
3.1.4.54 | capsaicin |
0.005 mM, 20% inhibition |
|
3.1.4.54 | Cd2+ |
10 mM, more than 90% inhibition |
|
3.1.4.54 | cetyltrimethylammonium chloride |
strongly inhibits the enzyme of all brain regions |
|
3.1.4.54 | Cu2+ |
- |
|